Your free order overview

You currently have not items to display

Your contact details

Title

Gender

First Name*

Last Name*

Email address*

Phone number

Country

Street

Number

City

Postal code

I agree to the Legal Notice

*

This is a required field

Thank you!

Thank you for choosing Janssen Medical Cloud for ordering your materials.

Home
Services
Services
- Ask J&J

Erleada^® Inhibits AR Signatlling at Multiple Sites of Action1

Erleada^® Inhibits AR Signatlling at Multiple Sites of Action¹

Reference:
1. ERLEADA^® (apalutamide) summary of product characteristics. Janssen, 2018.

CP-142079

This site is published by ©Johnson & Johnson Innovative Medicine NV which is solely responsible for its content. It is intended for European, Middle Eastern and African Healthcare professionals.

Johnson & Johnson Pharmaceutica NV

Legal Notice Cookie Policy Privacy Policy

Cookie Settings